Table 3.
Tissue-specificity comparison (by BioGPS) between euploid and aneuploid AF transcriptomes*
| Euploid | Turner Syndrome | Trisomy 21 | Trisomy 18 | |||||
|---|---|---|---|---|---|---|---|---|
| Genes | Percentage | Genes | Percentage | Genes | Percentage | Genes | Percentage | |
| Hematologic/Immune | 4 | 17.4% | 24 | 42.1% | 18 | 29.5% | 8 | 22.2% |
| Respiratory/Tongue/Skin | 6 | 26.1% | 4 | 7.0% | 15 | 24.6% | 12 | 33.3% |
| Neurologic | 7 | 30.4% | 19 | 33.3% | 12 | 19.7% | 6 | 16.7% |
| Gastrointestinal/Liver | 2 | 8.7% | 5 | 8.8% | 7 | 11.5% | 5 | 13.9% |
| Placenta | 2 | 8.7% | 0 | 0.0% | 5 | 8.2% | 2 | 5.6% |
| Reproductive/Endocrine | 2 | 8.7% | 3 | 5.3% | 4 | 6.6% | 3 | 8.3% |
| Cardiac | 0 | 0.0% | 1 | 1.8% | 0 | 0.0% | 0 | 0.0% |
| Fat | 0 | 0.0% | 1 | 1.8% | 0 | 0.0% | 0 | 0.0% |
*
number of Euploid samples =12, number of Turner samples =5, number of Trisomy 21 samples =7, number of Trisomy 18 samples = 5